<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The post-treatment effects of the selective cyclooxygenase (COX)-2 inhibitor, valdecoxib, were investigated in a rat model of temporary focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Valdecoxib reduced basal brain <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> E(2) concentrations at dosages that did not affect serum <z:chebi fb="0" ids="26995">thromboxane</z:chebi> B(2), consistent with a selective COX-2 effect </plain></SENT>
<SENT sid="2" pm="."><plain>Temporary focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was produced in rats by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 90 min </plain></SENT>
<SENT sid="3" pm="."><plain>There was increased expression of COX-2 protein detected by Western blot and immunocytochemistry within neurons in the ischemic cortex at 4 and 24 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Rats were treated with vehicle or valdecoxib 15 min before or 1.5, 3 and 6 h after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Rats were sacrificed and <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> volume determined 24 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Valdecoxib treatment was associated with a decrease in infarction volume when administered 15 min before, and 1.5 or 3 h but not 6 h after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>There were no differences in physiological parameters during the procedure </plain></SENT>
<SENT sid="8" pm="."><plain>Valdecoxib administered at 1.5 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> significantly reduced the concentrations of <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> E(2) in ischemic penumbral cortex as compared to the vehicle-treated group and contralateral non-ischemic cortex </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that COX-2 inhibition with valdecoxib is effective when initiated both before and after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
</text></document>